Mid-Term Outcome of Mechanical Pulmonary Valve Prostheses: The Importance of Anticoagulation

Abstract

Introduction: Pulmonary valve replacement (PVR) is being performed more commonly late after the correction of tetralogy of Fallot. Most valves are replaced with an allograft or xenograft, although reoperations are a common theme. Mechanical prostheses have a less favorable reputation due to the necessity of lifelong anticoagulation therapy and higher risk of thrombosis, but they are also less likely to require reoperation. There is a paucity of data on the use of prosthetic valves in the pulmonary position. We report the midterm outcomes of 38 cases of PVR with mechanical prostheses. Methods: One hundred twenty two patients who underwent PVR were studied. Thirty-eight patients, mean age 25 ± 8.4 years underwent PVR with mechanical prostheses based on the right ventricular function and the preferences of the patients and physicians. Median age of prosthesis was 1 year (range 3 months to 5 years). Results: Seven (18%) patients had malfunctioning pulmonary prostheses and two patients underwent redo PVR. Mean International Normalized Ratio (INR) in these seven patients was 2.1±0.8. Fibrinolytic therapy was tried and five of them responded to it well. There was no significant association between the severity of right ventricular dysfunction, patient’s age, prostheses valve size and age of the prosthesis in the patients with prosthesis malfunction. Conclusion: PVR with mechanical prostheses can be performed with promising midterm outcomes. Thrombosis on mechanical pulmonary valve prostheses remains a serious complication, but most prosthesis malfunction respond to fibrinolytic therapy, underscoring the need for adequate anticoagulation therapy.

Feasibility of On-table Extubation After Cardiac Surgery with Cardiopulmonary Bypass: A Randomized Clinical Trial

“…Another reason that favors the FTE method is the great adherence to a predefined protocol. The close involvement of intensivist, anesthesiologist, and trained nurses in this approach leads to shortened extubation time ( 14 , 42 , 43 ).…”

Pulmonary valve replacement in patients with corrected tetralogy of Fallot

“…Objective improvement in RV function and reduction in RV size, subsequent to PVR, has also been shown. 15 - 22 Bove and colleagues reported, in a group of 11 patients, favourable change in RV size by demonstrating significant reduction in cardiothoracic index as also diminished echocardiographic right to left ventricular end diastolic dimensions ratio. 18 Ilbawi et al displayed a significant reduction of the cardiothoracic index in 42 and a decrease in angiographically determined RV end systolic volumes in 18 patients.…”

“…The use of mechanical valves in the pulmonary position has been reported, but has significant drawbacks, largely due to the frequent occurrence of thromboembolic phenomena and valve failure. 15 , 22 …”

Pulmonary valve replacement with annulus enlargement for pulmonary valve infective endocarditis: A case report

“…In valve replacement on the right side of the heart with a mechanical valve, anticoagulation therapy with warfarin should be controlled more strictly than valve replacement on the left side of the heart. Mechanical valves also have more complications, including valve thrombosis or bleeding, than bio-prosthetic valves [7,8]. Alternatively, bio-prosthetic valves have the advantage of being free from the need for anticoagulant therapy, although they have a higher risk of re-operation, especially in young patients.…”